Studies of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one in thalassemia patients

Semin Hematol. 1990 Apr;27(2):101-4.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Chelation Therapy / methods*
  • Child
  • Deferiprone
  • Deferoxamine / therapeutic use
  • Drug Administration Schedule
  • Humans
  • Iron / urine
  • Iron Chelating Agents / therapeutic use*
  • Pilot Projects
  • Pyridones / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Thalassemia / therapy*
  • Thalassemia / urine
  • Transfusion Reaction*

Substances

  • Iron Chelating Agents
  • Pyridones
  • Deferiprone
  • Iron
  • Deferoxamine